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BackgroundᄏMicrobleeds (MBs), proposed as a biomarker for microangiopathy, have been 
suggested as a predictor of spontaneous or thrombolysis-related intracerebral hemorrhage (ICH) 
in acute ischemic stroke. However, the relationship between MBs and warfarin-induced ICH is 
not clear. 
Case ReportᄏWe describe two patients who developed warfarin-induced ICH at the site of 
MBs documented in previous MRI. 
ConclusionsᄏThe presence of MBs might increase the risk of ICH after warfarin use in is-
chemic stroke patients. A large cohort study is required to confirm the relationship of MBs with 
warfarin-induced ICH.  J Clin Neurol 2008;4:131-133
 
KEY WORDSᄏAnticoagulation, Intracerebral hemorrhage, Magnetic resonance imaging. 
 
 
Introduction 
 
The use of warfarin for preventing ischemic stroke in pati-
ents with atrial fibrillation has increased dramatically follow-
ing favorable results from randomized controlled trials in the 
1990s.
1 This is likely to increase the frequency of warfarin-
associated complications,
1,2 of which intracerebral hemorrhage 
(ICH) is the most serious and lethal, with a mortality of ap-
proximately 60%.
3 Thus, identifying the risk factors for war-
farin-induced ICH might be crucial to improving the risk-to-
benefit ratio of warfarin use, and considerable efforts have 
already been made to identify predictors of warfarin-induced 
ICH.
4,5 
An intracerebral microbleed (MB)-a small, dot-like signal 
loss best visualized on gradient-echo (GRE) imaging-has been 
regarded as a hemosiderin deposit caused by minor bleeding 
from advanced microangiopathy.
6 Recently there has been 
growing interest in the role of MBs as a potential risk factor 
for spontaneous or thrombolysis-related ICH in acute ische-
mic stroke.
7-11 Although MBs have been considered to be 
pathogenetically related with ICH, their significance as a risk 
factor for ICH is currently unclear due to inconsistent study 
results. Moreover, the relationship between MBs and war-
farin-induced ICH has never been addressed. Here we report 
two patients who developed warfarin-induced ICH in the area 
where MBs had been observed on previous GRE imaging, 
and discuss the role of MBs in the prediction of warfarin-
induced ICH. 
 
Case Report 
 
Case 1 
A 58-year-old woman visited the emergency room with sud-
den dysarthria. She had experienced a stroke 5 years previ-
ously, which was a right middle cerebral artery (MCA) ter-
ritory infarction. Hyperlipidemia was identified as a risk factor 
for stroke, and thus she had taken statin ever since. She had a 
left-sided sensory deficit as a sequela, but had no difficulties 
performing activities of daily living. She had been treated with 
warfarin because an embolism was presumed to have caused 
the stroke. There was no history of head trauma or known 
vascular malformation. On neurological examination, she had 
moderate dysarthria and a newly developed mild sensory de-
ficit on the right side. Otherwise, no new neurologic abnor-
mality was noted. Her blood pressure was 150/90 mmHg. 
Laboratory data including CRP were all within normal limits, 
except for a prothrombin time (PT) of 2.39 international nor-
malized ratio (INR). GRE imaging revealed an acute ICH in 
the area of the left parietal lobe (Fig. 1A). A review of the 
MRI images taken 5 years previously revealed an MB at the  
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same location where acute ICH had developed (Fig. 1B). 
We discontinued warfarin and administered fresh frozen pla-
sma and vitamin K. However, her symptoms gradually wor-
sened, and she had right-sided weakness (MRC grade III) 
and severe sensory deficit in the right hemibody at the time 
of discharge. 
 
Case 2 
A 78-year-old woman visited the emergency room due to 
altered mental status. She had a 5-year history of hypertension, 
diabetes mellitus, and atrial flutter. She had experienced a 
left MCA cardioembolic infarction 2 years previously, and 
had been treated with warfarin, oral hypoglycemic agent, and 
calcium-channel blocker without any neurologic deficits. She 
had no previous history of head trauma. On neurological exa-
mination, her mental status was semicomatose, and the light 
reflex in her right eye was sluggish. The corneal reflex and 
doll’s eye movement were absent. She was quadriplegic and 
showed Babinski’s sign on the left. The initial blood pressure 
was 130/60 mmHg and PT was 2.73 INR. The results of blood 
cell counts and CRP were unremarkable. Brain CT showed 
pontine hemorrhage (Fig. 2A). MRI performed 2 years pre-
viously showed an MB at the site of acute ICH (Fig. 2B). Her 
mental status deteriorated rapidly, and her self-respiration 
vanished. She died 1 month later. 
 
Discussion 
 
We experienced two patients who had taken warfarin and 
developed ICH at the location of MBs visualized on pre-
vious GRE imaging. Although the patients’ INR levels were 
within the therapeutic range, we believe that they reflected 
warfarin-induced ICH because we could not find any other 
causes of ICH such as increased blood pressure, trauma, vas-
cular malformation, or other coagulopathy. Therefore, we 
suggest that an MB is a preferential focus of ICH in patients 
receiving warfarin. To the best of our knowledge, this is the 
first study to explore the association between MBs and war-
farin-induced ICH. These two cases suggest that an MB is a 
potential risk factor for warfarin-induced ICH, and that infor-
mation from GRE imaging is valuable when deciding whether 
to prescribe warfarin for anticoagulation after ischemic stroke. 
Several previous studies have addressed the role of MBs 
in the prediction of ICH or hemorrhagic transformation in is-
chemic stroke patients. As for thrombolysis-related ICH, the 
initial study suggested an MB as a potential predictor of ICH 
after intra-arterial thrombolysis.
7 However, the subsequent 
studies failed to confirm the initial observation due to a lack 
of statistical power.
8,9 It seems unlikely that excluding patients 
solely based on MB will exceed the benefits gained from 
thrombolytic therapy. Regarding the short-term and long-
term risk of bleeding after antithrombotic therapy, previous 
studies have found that an MB was a significant independent 
predictor of hemorrhagic transformation within 1 week
10 and 
subsequent ICH during a 2-year follow-up
11 following an 
acute ischemic stroke. Whether the presence of an MB is 
indicative of a high risk of secondary ICH after thrombolysis 
or antithrombotic therapy is currently unclear from the pre-
vious studies due to data inconsistencies. 
The Stroke Prevention In Reversible Ischemia Trial (SPI-
RIT) pointed out that old age (>65 years), past history of 
cerebrovascular disease, and intensity of anticoagulation con-
stituted other clinical and radiological predictors of warfarin-
induced ICH.
4 Another study showed that the presence of 
leukoaraiosis was an independent, dose-dependent risk factor 
for poststroke warfarin-induced ICH.
5 Because the mechani-
sms underlying MBs and leukoaraiosis are thought to be 
similar (i.e., small-vessel disease), these studies indicate that 
the marker of chronic, advanced microangiopathy might lead 
to ICH. 
The mechanism by which warfarin induces ICH is not 
clear. Considering that the lesion distribution does not differ 
between warfarin-induced ICH and spontaneous ICH, their 
Fig. 2. CT and GRE images of case 2. A: Acute pontine hemor-
rhage was observed on CT. B: GRE images taken 2 years previo-
usly showed an MB at the site where acute ICH developed. GRE:
Gradient-echo, ICH: Intracerebral Hemorrhage. 
A  B 
Fig. 1. Gradient-echo (GRE) images of case 1. A: Acute intrace-
rebral hemorrhage (ICH) was observed in the left parietal lobe. B:
GRE images taken 5 years previously showed an intracerebral
microbleed (MB) in the left parietal lobe at the site of acute ICH. 
A  B  
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underlying processes might be similar. The presence of war-
farin could result in a tiny bleed enlarging even under normal 
hemostatic mechanisms.
3 Our patients also developed ICHs 
despite INR levels being within the therapeutic range. The 
use of warfarin therefore appears to unmask ICH that would 
otherwise remain asymptomatic. 
In conclusion, this case report suggests that the presence 
of MBs increases the risk of ICH after warfarin administra-
tion in ischemic stroke patients. Further large cohort studies 
are needed to confirm the association of MBs with warfarin-
induced ICH. 
 
Acknowledgment 
This study was supported by a grant of the Korea Health 21 R & D 
Project, Ministry of Health & Welfare, Republic of Korea (no. A060171). 
 
REFERENCES 
1. Stroke Prevention in Atrial Fibrillation Study. Final results. Circulation 
1991;84:527-539. 
2. Flaherty ML, Kissela B, Woo D, Kleindorfer D, Alwell K, Sekar P, et 
al. The increasing incidence of anticoagulant-associated intracerebral 
hemorrhage. Neurology 2007;68:116-121. 
3. Hart RG, Boop BS, Anderson DC. Oral anticoagulants and intracra-
nial hemorrhage. Facts and hypotheses. Stroke 1995;26:1471-1477. 
4. Bleeding during antithrombotic therapy in patients with atrial fibril-
lation. The Stroke Prevention in Atrial Fibrillation Investigators. Arch 
Intern Med 1996;156:409-416. 
5. Smith EE, Rosand J, Knudsen KA, Hylek EM, Greenberg SM. Leu-
koaraiosis is associated with warfarin-related hemorrhage following 
ischemic stroke. Neurology 2002;59:193-197. 
6. Tanaka A, Ueno Y, Nakayama Y, Takano K, Takebayashi S. Small 
chronic hemorrhages and ischemic lesions in association with spon-
taneous intracerebral hematomas. Stroke 1999;30:1637-1642. 
7. Kidwell CS, Saver JL, Villablanca JP, Duckwiler G, Fredieu A, Gough 
K, et al. Magnetic resonance imaging detection of microbleeds before 
thrombolysis: an emerging application. Stroke 2002;33:95-98. 
8. Derex L, Nighoghossian N, Hermier M, Adeleine P, Philippeau F, 
Honnorat J, et al. Thrombolysis for ischemic stroke in patients with 
old microbleeds on pretreatment MRI. Cerebrovasc Dis 2004;17:238-
241. 
9. Fiehler J, Albers GW, Boulanger JM, Derex L, Gass A, Hjort N, et al. 
Bleeding Risk Analysis in Stroke Imaging before thromboLysis (B-
RASIL): pooled analysis of T2*-weighted magnetic resonance imaging 
data from 570 patients. Stroke 2007;38:2738-2744. 
10. Nighoghossian N, Hermier M, Adeleine P, Blanc-Lasserre K, Derex 
L, Honnorat J, et al. Old microbleeds are a potential risk factor for 
cerebral bleeding after ischemic stroke: a gradient-echo T2*-weighted 
brain MRI study. Stroke 2002;33:735-742. 
11. Fan YH, Zhang L, Lam WW, Mok VC, Wong KS. Cerebral microbl-
eeds as a risk factor for subsequent intracerebral hemorrhages among 
patients with acute ischemic stroke. Stroke 2003;34:2459-2462. 
 
 